These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 21036356)

  • 1. Beyond C-reactive protein; new evidence for another inflammatory biomarker predicting cardiovascular disease risk.
    Kajinami K; Kawai Y
    Atherosclerosis; 2011 Jan; 214(1):39-40. PubMed ID: 21036356
    [No Abstract]   [Full Text] [Related]  

  • 2. Inflammatory markers for risk stratification in primary prevention of cardiovascular disease: time for a 'multimarker' approach?
    Ikonomidis I; Lekakis J; Kremastinos DT
    Thromb Haemost; 2006 Mar; 95(3):397-8. PubMed ID: 16525564
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronary artery disease prognosis and C-reactive protein levels improve in proportion to percent lowering of low-density lipoprotein.
    O'Keefe JH; Cordain L; Jones PG; Abuissa H
    Am J Cardiol; 2006 Jul; 98(1):135-9. PubMed ID: 16784936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein for risk assessment in coronary artery disease.
    Danchin N
    Heart; 2010 Mar; 96(5):325-7. PubMed ID: 19933748
    [No Abstract]   [Full Text] [Related]  

  • 5. C reactive protein--marker for atherothrombotic events.
    Gogna A; Sinha RS; Gupta B
    J Assoc Physicians India; 1999 Jun; 47(6):631-3. PubMed ID: 10999165
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers for early detection of risk in female patients with coronary artery disease: pilot study.
    Mahto S; Sharma SB; Dwivedi S; Puri D; Tripathi RL
    J Assoc Physicians India; 2013 May; 61(5):317-9. PubMed ID: 24482944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?
    Yousuf O; Mohanty BD; Martin SS; Joshi PH; Blaha MJ; Nasir K; Blumenthal RS; Budoff MJ
    J Am Coll Cardiol; 2013 Jul; 62(5):397-408. PubMed ID: 23727085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRP as a marker for cardiovascular risk.
    Savill P
    Practitioner; 2008 Dec; 252(1713):4. PubMed ID: 19192697
    [No Abstract]   [Full Text] [Related]  

  • 9. Pregnancy-associated plasma protein-A and cardiovascular risk.
    Kaski JC; Holt DW
    Eur Heart J; 2006 Jul; 27(14):1637-9. PubMed ID: 16790470
    [No Abstract]   [Full Text] [Related]  

  • 10. C-reactive protein--marker for atherothrombotic events.
    Gogna A; Sinha RS; Gupta B
    J Assoc Physicians India; 1999 Aug; 47(8):818-20. PubMed ID: 10778631
    [No Abstract]   [Full Text] [Related]  

  • 11. Pregnancy-associated plasma protein-A (PAPP-A) and cardiovascular risk.
    Consuegra-Sanchez L; Fredericks S; Kaski JC
    Atherosclerosis; 2009 Apr; 203(2):346-52. PubMed ID: 18789800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein is an essential aspect of cardiovascular risk factor stratification.
    Yeh ET
    Can J Cardiol; 2004 Aug; 20 Suppl B():93B-96B. PubMed ID: 15309212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High sensitive C-reactive protein: a novel biochemical markers and its role in coronary artery disease.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jan; 53():25-32. PubMed ID: 15857009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women].
    Biasucci LM
    Ital Heart J Suppl; 2000 Aug; 1(8):1066-7. PubMed ID: 10993018
    [No Abstract]   [Full Text] [Related]  

  • 15. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
    Koenig W
    Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of C-reactive protein in patients with stable coronary artery disease: JUPITER in perspective.
    Saely CH; Rein P; Vonbank A; Drexel H
    Int J Cardiol; 2010 Oct; 144(3):448-9. PubMed ID: 19351576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: report from the clinical practice discussion group.
    Smith SC; Anderson JL; Cannon RO; Fadl YY; Koenig W; Libby P; Lipshultz SE; Mensah GA; Ridker PM; Rosenson R; ;
    Circulation; 2004 Dec; 110(25):e550-3. PubMed ID: 15611380
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between baseline inflammatory markers, antiplatelet therapy, and adverse cardiac events after percutaneous coronary intervention: an analysis from the clopidogrel for the reduction of events during observation trial.
    Dosh K; Berger PB; Marso S; van Lente F; Brennan DM; Charnigo R; Topol EJ; Steinhubl S
    Circ Cardiovasc Interv; 2009 Dec; 2(6):503-12. PubMed ID: 20031767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diurnal and seasonal patterns in inflammation-sensitive biomarker level.
    Dominguez-Rodriguez A; Abreu-Gonzalez P
    Am J Cardiol; 2009 Jan; 103(2):293. PubMed ID: 19121457
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein, cardiovascular disease and stroke: new roles for an old biomarker.
    Willcox BJ; Abbott RD; Yano K; Rodriguez BL; Willcox DC; Curb JD
    Expert Rev Neurother; 2004 May; 4(3):507-18. PubMed ID: 15853546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.